Trigeminal Neuralgia News and Research

RSS
Trigeminal neuralgia (TN), also called tic douloureux, is a chronic pain condition that causes extreme, sporadic, sudden burning or shock-like face pain.  The pain seldom lasts more than a few seconds or a minute or two per episode. The intensity of pain can be physically and mentally incapacitating. TN pain is typically felt on one side of the jaw or cheek. Episodes can last for days, weeks, or months at a time and then disappear for months or years.  In the days before an episode begins, some patients may experience a tingling or numbing sensation or a somewhat constant and aching pain.  The attacks often worsen over time, with fewer and shorter pain-free periods before they recur.  The intense flashes of pain can be triggered by vibration or contact with the cheek (such as when shaving, washing the face, or applying makeup), brushing teeth, eating, drinking, talking, or being exposed to the wind.  TN occurs most often in people over age 50, but it can occur at any age, and is more common in women than in men.  There is some evidence that the disorder runs in families, perhaps because of an inherited pattern of blood vessel formation. Although sometimes debilitating, the disorder is not life-threatening.
FDA grants orphan-drug designation to Convergence's CNV1014802 for treatment of TN

FDA grants orphan-drug designation to Convergence's CNV1014802 for treatment of TN

Orlando Health and UF health partner to expand neurosurgery program

Orlando Health and UF health partner to expand neurosurgery program

AANS, CNS urge Congress to restore Medicare payments for stereotactic radiosurgery

AANS, CNS urge Congress to restore Medicare payments for stereotactic radiosurgery

HSS involving resiniferatoxin receives U.S. patent to alleviate intractable pain

HSS involving resiniferatoxin receives U.S. patent to alleviate intractable pain

Neuros Medical honored as most promising startup

Neuros Medical honored as most promising startup

AMS announces FDA clearance of MEVION S250 Proton Therapy System

AMS announces FDA clearance of MEVION S250 Proton Therapy System

Convergence initiates CNV1014802 Phase II study in trigeminal neuralgia

Convergence initiates CNV1014802 Phase II study in trigeminal neuralgia

American Shared Hospital Services fourth quarter revenues increase 8.4% to $4,500,000

American Shared Hospital Services fourth quarter revenues increase 8.4% to $4,500,000

American Shared Hospital Services third quarter revenue increases to $9,148,000

American Shared Hospital Services third quarter revenue increases to $9,148,000

AMS pleased with CMS' increase in 2012 payment rate for proton therapy

AMS pleased with CMS' increase in 2012 payment rate for proton therapy

Laser Med Center receives FDA approval for device to treat Trigeminal Neuralgia

Laser Med Center receives FDA approval for device to treat Trigeminal Neuralgia

Microvascular compression syndrome may cause Parkinson's

Microvascular compression syndrome may cause Parkinson's

American Shared Hospital Services first half 2011 revenues increase 4.0% to $8,573,000

American Shared Hospital Services first half 2011 revenues increase 4.0% to $8,573,000

Vampire bats can smell blood-rich prey: Study

Vampire bats can smell blood-rich prey: Study

Lovelace Medical Center upgrades to Gamma Knife Perfexion system

Lovelace Medical Center upgrades to Gamma Knife Perfexion system

Pitt, UPCI researchers' cancer studies presented at AACR meeting

Pitt, UPCI researchers' cancer studies presented at AACR meeting

Positive results from Neuros Medical Electrical Nerve Block technology study in chronic pain

Positive results from Neuros Medical Electrical Nerve Block technology study in chronic pain

Avanir files IND for NUEDEXTA/AVP-923 Phase II clinical trial for central neuropathic pain in MS patients

Avanir files IND for NUEDEXTA/AVP-923 Phase II clinical trial for central neuropathic pain in MS patients

Researchers identify gene that can predict hypersensitivity to epilepsy drug

Researchers identify gene that can predict hypersensitivity to epilepsy drug

Brain surgeon partners with NASA's JPL to design high-tech surgical instruments

Brain surgeon partners with NASA's JPL to design high-tech surgical instruments

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.